Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Healthcare Reporter.
Press releases published on June 30, 2025

Algernon Announces Amended Terms for Private Placement and Closing of the First Tranche totaling $621,000
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), …

Academy Announces Host, Executive Producer and Author Andy Cohen as 2025 FNCE® Closing Keynote Speaker
CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- Food and nutrition experts from around the world will gather in Nashville, Tenn., October 11-14, for the Academy of Nutrition and Dietetics' 2025 Food …

InstantGMP Amplía el Alcance de su Software en Español en Toda América Latina
CARY, NC, UNITED STATES, June 30, 2025 /EINPresswire.com/ -- Como parte de su creciente compromiso con el apoyo a fabricantes de productos farmacéuticos y suplementos en países de habla hispana, InstantGMP™ se enorgullece en anunciar nuevas iniciativas …

East West Kung Fu Studios Honors the Life and Legacy of Senior Grandmaster Richard Lee (1942–2025)
ALAMO, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- With deep respect and profound sorrow, East West Kung Fu Studios announces the passing of our beloved founder, Senior Grandmaster Richard Lee, a once-in-a-generation martial artist, visionary educator and …

TerrAscend Announces Strategic Exit from Michigan Market
Net Proceeds from divestitures to pay down Company debt Enables concentrated growth and improved profitability in core markets TORONTO, June 30, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend”) (TSX: TSND, OTCQX: TSNDF), a leading North American …

Aptose Announces Deferral of Interest Payment
SAN DIEGO and TORONTO, June 30, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat …

Egg Powder Market is poised to surpass USD 1.5 billion by 2032, showcasing a CAGR of 5.1%
The rising preference for convenient and ready-to-eat food products is a significant driver for the egg powder market. WILMINGTON, DE, UNITED STATES, June 30, 2025 /EINPresswire.com/ -- Egg powder market size was valued at $923.7 million in 2022 and is …

Avalue Unveils MAB-T660: The Latest Edge AI Box PC Powering AI in Every Corner
MAB-T660, a slim ,AI-ready barebone system meticulously engineered for seamless integration into medical and retail ecosystems. NEW TAIPEI CITY, TAIWAN, June 30, 2025 /EINPresswire.com/ -- Avalue Technology Inc. (TPEx: 3479.TWO), a global leader in …

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, June 30, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation antibody-drug conjugate (‘ADC’) therapeutics for difficult-to-treat cancers, reported today that Pyxis Oncology’s …

Ovation Fertility AI Research Abstract Selected for Presentation at ESHRE 2025
PARIS, FRANCE, June 30, 2025 /EINPresswire.com/ -- Ovation® Fertility’s groundbreaking research on the use of artificial intelligence in embryo selection has been accepted for presentation at the renowned European Society of Human Reproduction and …

PetVivo Reports Fiscal 2025 Results
MINNEAPOLIS, MN, US, June 30, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. and its wholly-owned subsidiary PetVivo Animal Health, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leading biomedical company delivering innovative medical therapeutics for equines and …

Revolutionizing Respiratory Care: Adam DME Unveils Advanced Nebulizer Solutions
FREDERICK, MD, UNITED STATES, June 30, 2025 /EINPresswire.com/ -- Adam DME, a leader in durable medical equipment, is transforming respiratory therapy with its latest innovation: a cutting-edge line of nebulizers designed for faster, more efficient …

The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada
CERRITOS, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that effective July 1, it will be the exclusive oncology provider …

INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Boca Raton, Florida, June 30, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it has closed its registered direct offering, announced on June 27, 2025, (the …

Dyne Therapeutics Announces Proposed Public Offering of Common Stock
WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it has …

Gain Therapeutics Announces Completion of Target Enrollment in Phase 1b Clinical Study Evaluating GT-02287 in People With Parkinson’s Disease With or Without a GBA1 Mutation
As of June 30th, 16 participants have enrolled in the Phase 1b, ahead of the original goal of at least 15 total participants by 3Q 2025 Analysis of 90-day biomarker activity from cerebrospinal fluid (CSF) in all participants currently enrolled is now …

Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline
Long-term efficacy and safety data on PALSONIFYTM (paltusotine) in acromegaly to be presented, including evidence of both biochemical and symptom control with a well-tolerated safety profile in patients switching treatments and those not previously …

Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital
- $100 million funded upfront; additional $175 million tied to milestones provides strategic flexibility through key inflection points - WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company …

I-Mab Announces Publication of Givastomig Monotherapy Data in Clinical Cancer Research
Monotherapy efficacy and safety profile provided backbone for clinical development strategy in 1L combination with nivolumab plus chemotherapy ROCKVILLE, MD, June 30, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech …

Globavend and Strawberrynet Cosmetics Execute Strategic Partnership
Globavend and Strawberrynet executed strategic partnership to bring top online beauty products retailer to $8 billion Australian beauty and cosmetic market Globavend Holdings Limited (NASDAQ:GVH) PERTH, AUSTRALIA, June 30, 2025 /EINPresswire.com/ -- …